Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-042152 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,229
Total Value
$31,895.66
P&L
+7.9% (+$2,521.88)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Sep 8, 2026 | Purchase | 9,393 | $2.10 | $19,699.00 | 2,769,393 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Sep 9, 2026 | Purchase | 5,836 | $2.09 | $12,196.66 | 2,775,229 | Indirect | By Opaleye, L.P. | View Details |